Jazz Pharmaceuticals, Inc. (JAZZ) Tops Q1 EPS by 7c
Tweet
Share
E-mailGet Alerts JAZZ Hot Sheet
Price: $234.88 -2.37%
EPS Growth %: -20.4%
Financial Fact:
Total operating expenses: 237.93M
Today's EPS Names:
OCCI, ALZN, ASPU, More
EPS Growth %: -20.4%
Financial Fact:
Total operating expenses: 237.93M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Jazz Pharmaceuticals, Inc. (NASDAQ: JAZZ) reported Q1 EPS of $0.91, $0.07 better than the analyst estimate of $0.84.
For earnings history and earnings-related data on Jazz Pharmaceuticals, Inc. (JAZZ) click here.
For earnings history and earnings-related data on Jazz Pharmaceuticals, Inc. (JAZZ) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stitch Fix (SFIX) Tops Q4 EPS by 4c; Offers Guidance
- NeoVolta Inc. (NEOV) Misses Q3 EPS by 17c
- TransUnion CFO Todd Cello to step down after 29 years
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
